These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
106 related items for PubMed ID: 2148084
1. Role of Mg++ in the mithramycin-DNA interaction: evidence for two types of mithramycin-Mg++ complex. Aich P, Dasgupta D. Biochem Biophys Res Commun; 1990 Dec 14; 173(2):689-96. PubMed ID: 2148084 [Abstract] [Full Text] [Related]
2. Interaction of the DNA-binding antitumor antibiotics, chromomycin and mithramycin with erythroid spectrin. Majee S, Dasgupta D, Chakrabarti A. Eur J Biochem; 1999 Mar 14; 260(3):619-26. PubMed ID: 10102989 [Abstract] [Full Text] [Related]
4. Role of magnesium ion in the interaction between chromomycin A3 and DNA: binding of chromomycin A3-Mg2+ complexes with DNA. Aich P, Sen R, Dasgupta D. Biochemistry; 1992 Mar 24; 31(11):2988-97. PubMed ID: 1550824 [Abstract] [Full Text] [Related]
6. Interactions of chromomycin A3 and mithramycin with the sequence d(TAGCTAGCTA)2. Chakrabarti S, Dasgupta D. Indian J Biochem Biophys; 2001 Mar 24; 38(1-2):64-70. PubMed ID: 11563333 [Abstract] [Full Text] [Related]
7. Biostructural chemistry of magnesium. regulation of mithramycin-DNA interactions by Mg2+ coordination. Huang HW, Li D, Cowan JA. Biochimie; 1995 Mar 24; 77(9):729-38. PubMed ID: 8789464 [Abstract] [Full Text] [Related]
10. Association of antitumor antibiotic Mithramycin with Mn2+ and the potential cellular targets of Mithramycin after association with Mn2+. Dutta S, Lahiri S, Banerjee A, Saha S, Dasgupta D. J Biomol Struct Dyn; 2015 Mar 24; 33(2):434-46. PubMed ID: 24559512 [Abstract] [Full Text] [Related]
13. Mithramycin cannot bind to left-handed poly(dG-m5dC) in the presence of Mg2+ ion. Demicheli C, Garnier-Suillerot A. Biochem Biophys Res Commun; 1991 May 31; 177(1):511-7. PubMed ID: 1828342 [Abstract] [Full Text] [Related]
14. Interaction between antitumor antibiotic chromomycin A3 and Mg2+. I. Evidence for the formation of two types of chromomycin A3-Mg2+ complexes. Aich P, Sen R, Dasgupta D. Chem Biol Interact; 1992 Jun 15; 83(1):23-33. PubMed ID: 1643666 [Abstract] [Full Text] [Related]
16. Mithramycin: a very strong metal chelating agent. Demicheli C, Garnier-Suillerot A. Biochim Biophys Acta; 1993 Aug 20; 1158(1):59-64. PubMed ID: 8353132 [Abstract] [Full Text] [Related]
17. Interaction of antitumor drug, mithramycin, with chromatin. Mir MA, Dasgupta D. Biochem Biophys Res Commun; 2001 Jan 12; 280(1):68-74. PubMed ID: 11162479 [Abstract] [Full Text] [Related]
18. A DNA-binding antitumor antibiotic binds to spectrin. Majee S, Chakrabarti A. Biochem Biophys Res Commun; 1995 Jul 17; 212(2):428-32. PubMed ID: 7626057 [Abstract] [Full Text] [Related]
19. The three-dimensional structure of the 4:1 mithramycin:d(ACCCGGGT)(2) complex: evidence for an interaction between the E saccharides. Keniry MA, Owen EA, Shafer RH. Biopolymers; 2000 Aug 17; 54(2):104-14. PubMed ID: 10861371 [Abstract] [Full Text] [Related]
20. N-terminal tail domains of core histones in nucleosome block the access of anticancer drugs, mithramycin and daunomycin, to the nucleosomal DNA. Mir MA, Das S, Dasgupta D. Biophys Chem; 2004 Apr 01; 109(1):121-35. PubMed ID: 15059665 [Abstract] [Full Text] [Related] Page: [Next] [New Search]